跳至主要内容
临床试验/NCT03320694
NCT03320694已完成3 期

Comparison of Metformin and Insulin for Management of Gestational Diabetes Mellitus

Services Institute of Medical Sciences, Pakistan1 个研究点 分布在 1 个国家目标入组 278 人开始时间: 2016年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
278
试验地点
1
主要终点
maternal glycemic control

研究概览

简要总结

Gestational diabetic mellitus (GDM) patients randomised to metformin or insulin group.Aim was to achieve blood sugar levels of Blood sugar fasting (BSF) <5.3 mmol/l and 1 hour post meal<7.8mmol/l. Both groups were followed till delivery and outcome studied.

详细描述

75 gm Oral Glucose Tolerance Test (OGTT) was done in pregnant patients. Blood sugar fasting(BSF) > 5.5 mmol/l & 2 hours postprandial >7.8 mmol/l was labelled as GDM. They were randomised to metformin or insulin group. Those assigned to metformin group were started metformin 500mg twice daily & increased until 2500mg depending on the blood sugar levels. Aim was to achieve blood sugar levels of BSF <5.3 mmol/l and 1 hour post meal<7.8mmol/l. If blood sugar levels were not controlled, insulin was added. The insulin group was given 3 injections of regular insulin & one intermediate acting insulin injection at night subcutaneously. Both groups were followed till delivery and outcome studied

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • All pregnant Diagnosed GDM in pregnancy by OGTT from 22 week to 34 week with singleton pregnancy

排除标准

  • Patients with Known diabetes mellitus
  • Patients with multiple pregnancy
  • With essential hypertension or pre eclampsia
  • Patients having fetal malformation incompatible with life
  • Patients with intrauterine death of fetus

研究组 & 干预措施

metformin

Experimental

Metformin will be given until 2500mg in divided doses till normoglycemia is achieved and will be continued till delivery

干预措施: Metformin (Drug)

Insulin

Active Comparator

Insulin will be give as 3 regular injection and one intermediate acting injection at bedtime till normoglycemia is achieved and will be continued till delivery

干预措施: Insulin (Drug)

结局指标

主要结局

maternal glycemic control

时间窗: From time of randomisation till 40 weeks

Maternal glycemic control was measured by blood sugar levels

次要结局

  • Perinatal death(7 days of delivery)
  • Neonatal hypoglycemia(at birth)
  • mode of delivery(at delivery)
  • Neonatal intensive care unit (NICU) stay(>24 hours after birth)
  • Fetal macrosomia(at birth)
  • Apgar score(at birth)

研究者

发起方
Services Institute of Medical Sciences, Pakistan
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Tayyiba Wasim

Professor Obs Gynae

Services Institute of Medical Sciences, Pakistan

研究点 (1)

Loading locations...

相似试验